Phase
Condition
Liver Disorders
Liver Disease
Neurologic Disorders
Treatment
Branch Chain Amino Acid
Lactulose
Clinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 18-75 years
Either gender
Patients with ACLF (CANONIC definition) of any etiology with HE ≥grade 2 as perWest-Haven Criteria
Exclusion
Exclusion Criteria:
Those who do not consent to participate in the study
Patients with structural brain lesions or stroke
Inability to obtain informed consent from patient or relatives
Severe preexisting cardiopulmonary disease
Renal dysfunction (S. Creatinine ≥ 2mg/dL)
Pregnancy/Lactation
Post liver transplant patients
HIV infection
Patients who are on psychoactive drugs, like sedatives or antidepressants
Patients who are too sick to carry out the protocol.
Study Design
Study Description
Connect with a study center
Dr. Madhumita Premkumar
Chandigarh, 160012
IndiaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.